Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Barra

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|July 1, 1996
Serum and salivary antigliadin antibodies and serum IgA anti-endomysium antibodies as a screening test for coeliac diseaseJ Rujner, J Socha, E Barra, et al.
Pathologica|November 1, 1987
[Adenocarcinoma of the uterus: presentation of 3 cases]G De Rosa, L Palombini, P Zeppa, et al.
Genitourinary Medicine|August 1, 1989
Verruciform xanthoma of the vulva: case reportG de Rosa, E Barra, R Gentile, et al.
Journal of Thrombosis and Thrombolysis|January 5, 2021
Evaluation of direct thrombin inhibitors during a critical heparin shortageChristine S Ji, Russel J Roberts, Megan E Barra, et al.
Journal of Pharmacy Practice|February 14, 2022
Efficacy and Safety of Immediate-Release Nifedipine in Critically Ill PatientsStephanie L Seto, Megan E Barra, Arzo Hamidi, et al.
Journal of Cutaneous Pathology|October 1, 1993
p53 protein in aggressive and non-aggressive basal cell carcinomaG De Rosa, S Staibano, E Barra, et al.
Neurocritical Care|September 28, 2022
Safety and Tolerability of 23.4% Hypertonic Saline Administered Over 2 to 5 Minutes for the Treatment of Cerebral Herniation and Intracranial Pressure ElevationSean K O'Brien, Jennifer L Koehl, Lindsay B Demers, et al.
Cancer|January 1, 1992
Nucleolar organizer regions in aggressive and nonaggressive basal cell carcinoma of the skinG De Rosa, S Staibano, E Barra, et al.
Tumori|June 30, 1990
Complete regression of laryngeal involvement by classic Kaposi's sarcoma with low-dose alpha-2b interferonC Gridelli, G Palmieri, G Airoma, et al.
Journal of Intensive Care Medicine|April 11, 2019
Stimulant Therapy in Acute Traumatic Brain Injury: Prescribing Patterns and Adverse Event Rates at 2 Level 1 Trauma CentersMegan E Barra, Saef Izzy, Aliyah Sarro-Schwartz, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Acta Paediatrica (Oslo, Norway : 1992)|July 1, 1996
Serum and salivary antigliadin antibodies and serum IgA anti-endomysium antibodies as a screening test for coeliac diseaseJ Rujner, J Socha, E Barra, et al.
Pathologica|November 1, 1987
[Adenocarcinoma of the uterus: presentation of 3 cases]G De Rosa, L Palombini, P Zeppa, et al.
Genitourinary Medicine|August 1, 1989
Verruciform xanthoma of the vulva: case reportG de Rosa, E Barra, R Gentile, et al.
Journal of Thrombosis and Thrombolysis|January 5, 2021
Evaluation of direct thrombin inhibitors during a critical heparin shortageChristine S Ji, Russel J Roberts, Megan E Barra, et al.
Journal of Pharmacy Practice|February 14, 2022
Efficacy and Safety of Immediate-Release Nifedipine in Critically Ill PatientsStephanie L Seto, Megan E Barra, Arzo Hamidi, et al.
Journal of Cutaneous Pathology|October 1, 1993
p53 protein in aggressive and non-aggressive basal cell carcinomaG De Rosa, S Staibano, E Barra, et al.
Neurocritical Care|September 28, 2022
Safety and Tolerability of 23.4% Hypertonic Saline Administered Over 2 to 5 Minutes for the Treatment of Cerebral Herniation and Intracranial Pressure ElevationSean K O'Brien, Jennifer L Koehl, Lindsay B Demers, et al.
Cancer|January 1, 1992
Nucleolar organizer regions in aggressive and nonaggressive basal cell carcinoma of the skinG De Rosa, S Staibano, E Barra, et al.
Tumori|June 30, 1990
Complete regression of laryngeal involvement by classic Kaposi's sarcoma with low-dose alpha-2b interferonC Gridelli, G Palmieri, G Airoma, et al.
Journal of Intensive Care Medicine|April 11, 2019
Stimulant Therapy in Acute Traumatic Brain Injury: Prescribing Patterns and Adverse Event Rates at 2 Level 1 Trauma CentersMegan E Barra, Saef Izzy, Aliyah Sarro-Schwartz, et al.
Pageof 9